NCT02359968 2026-03-18
PROTECT
Centre Oscar Lambret
Phase 2 Completed
Clinical Trials
5,373 trialsNCT02642809 2026-03-18
Pembrolizumab With Locally Delivered Radiation Therapy for the Treatment of Metastatic Esophageal Cancers
Washington University School of Medicine
Phase 1 Completed
NCT07479264 2026-03-18
A Study on Intratumoral Fibrosis and α-SMA Expression in Intrahepatic Cholangiocarcinoma
First Affiliated Hospital, Sun Yat-Sen University
Completed
NCT03292289 2026-03-17
QUALIPRO
Centre Oscar Lambret
Phase NA Completed
NCT02437656 2026-03-16
METCAP
Centre Oscar Lambret
Phase 2 Completed
NCT06643026 2026-03-16
SENSEO
Hospices Civils de Lyon
Completed
NCT00905047 2026-03-13
COLOCROSS
Centre Oscar Lambret
Phase 3 Completed
NCT01046487 2026-03-13
PALANGI3
Centre Oscar Lambret
Phase 1 Completed
NCT01165346 2026-03-13
CKNO-HEP
Centre Oscar Lambret
Phase 2 Completed
NCT02310477 2026-03-13
REBECCA
Centre Oscar Lambret
Completed
NCT02648282 2026-03-13
Study With CY, Pembrolizumab, GVAX Pancreas Vaccine, and SBRT in Patients With Locally Advanced Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT03151213 2026-03-13
pregabalin
Tanta University
Phase 4 Completed
NCT04301778 2026-03-13
Durvalumab and SNDX-6532 Following Chemo or Radio-Embolization for Patients With Intrahepatic Cholangiocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT06381648 2026-03-13
LyMIC
City of Hope Medical Center
Completed
NCT06654622 2026-03-13
Exosome-based Detection of Molecular Residual Disease in Stage II-III Colorectal Cancer
City of Hope Medical Center
Completed
NCT01904955 2026-03-12
Should Colorectal Cancer Patients be Followed After Five Years? Study of Recurrence in a Population Cohort
Centre Hospitalier Universitaire Dijon
Completed
NCT02386397 2026-03-12
BREGO
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 1/2 Completed
NCT03223779 2026-03-12
Study of TAS-102 Plus Radiation Therapy for the Treatment of the Liver in Patients With Hepatic Metastases From Colorectal Cancer
Massachusetts General Hospital
Phase 1/2 Completed
NCT03239145 2026-03-12
Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor
Dana-Farber Cancer Institute
Phase 1 Completed
NCT07193316 2026-03-12
SEEK
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Completed
NCT02829918 2026-03-11
Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Completed
NCT07102329 2026-03-11
ESCAPE
IRCCS San Raffaele
Completed
NCT03367247 2026-03-10
BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and Renewal
Dana-Farber Cancer Institute
Phase NA Completed
NCT03446157 2026-03-10
Palbociclib and Cetuximab in Metastatic Colorectal Cancer
UNC Lineberger Comprehensive Cancer Center
Phase 2 Completed
NCT04194268 2026-03-10
PACK
University Hospital Heidelberg
Phase NA Completed
NCT07460596 2026-03-10
Concentrated Complex Plant Dietary Elements for Chemotherapy-Induced Diarrhea
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Completed
NCT00102011 2026-03-09
00-046
Memorial Sloan Kettering Cancer Center
Phase 3 Completed
NCT05162846 2026-03-09
MiGHT
University of Michigan Rogel Cancer Center
Phase NA Completed
NCT05665348 2026-03-09
TRIPLET
Federation Francophone de Cancerologie Digestive
Phase 2/3 Completed
NCT02047474 2026-03-06
Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer
Yale University
Phase 2 Completed
NCT03259763 2026-03-06
EUS-GE vs ES for Palliation of Gastric Outlet Obstruction
Johns Hopkins University
Phase NA Completed
NCT03322267 2026-03-06
Adjuvant Pembrolizumab for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma at High Risk of Recurrence
National Taiwan University Hospital
Phase 2 Completed
NCT04705818 2026-03-06
CAIRE
Institut Bergonié
Phase 2 Completed
NCT06184867 2026-03-06
CATALYST
Rutgers, The State University of New Jersey
Phase NA Completed
NCT07453433 2026-03-06
Submucosal Pressure Ejection Endoscopic Dissection for Early Gastric Cancer: a Retrospective Cohort Study
Shanghai East Hospital
Completed
NCT06071052 2026-03-05
DREAM
First Affiliated Hospital, Sun Yat-Sen University
Phase 2 Completed
NCT06955468 2026-03-04
Prime GOC
Abramson Cancer Center at Penn Medicine
Phase NA Completed
NCT03519412 2026-03-03
ARETHUSA
IFOM ETS - The AIRC Institute of Molecular Oncology
Phase 2 Completed
NCT06263205 2026-03-03
Dressing
Fudan University
Phase NA Completed
NCT06686966 2026-03-03
Prediction of Postoperative Complications and Survival in Gastric Cancer Using Preoperative Blood Markers
First Affiliated Hospital of Chongqing Medical University
Completed
NCT06866678 2026-03-03
Frailty Score and Postoperative Morbidity in Colorectal Cancer Surgery
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Completed
NCT07180303 2026-03-03
CRC-RPHC
The First Affiliated Hospital with Nanjing Medical University
Phase NA Completed
NCT07445178 2026-03-03
Piecemeal Resection and Advanced Histology Independently Predict Local Recurrence After Colorectal Snare-based Endoscopic Resection: a Time-to-event Cohort Study
University of Sao Paulo
Completed
NCT07446946 2026-03-03
POlig
Medizinische Hochschule Brandenburg Theodor Fontane
Completed
NCT02110498 2026-03-02
Early Detection of Pancreatic Cystic Neoplasms
Johns Hopkins University
Completed
NCT03686488 2026-03-02
TAS 102 in Combination With Ramucirumab in Advanced, Refractory Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Completed
NCT01202136 2026-02-27
PCyst
Johns Hopkins University
Completed
NCT03510858 2026-02-27
Randomized Controlled Trial on Colorectal Cancer Screening Among Quality Circles of Primary Care Physicians
University of Bern
Phase NA Completed
NCT03640208 2026-02-27
Educate, Assess Risk and Overcoming Barriers to Colorectal Screening Among African Americans
Case Comprehensive Cancer Center
Phase NA Completed
NCT03828799 2026-02-27
FOLFIRINOX-R
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 1/2 Completed